<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Exp Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp Neurobiol</journal-id>
<journal-id journal-id-type="publisher-id">EN</journal-id>
<journal-title-group>
<journal-title>Experimental Neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-2560</issn>
<issn pub-type="epub">2093-8144</issn>
<publisher>
<publisher-name>The Korean Society for Brain and Neural Science</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31308794</article-id>
<article-id pub-id-type="pmc">6614072</article-id>
<article-id pub-id-type="doi">10.5607/en.2019.28.3.337</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Early-Life Stress in D2 Heterozygous Mice Promotes Autistic-like Behaviors through the Downregulation of the BDNF-TrkB Pathway in the Dorsal Striatum</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Yunjin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Han</surname>
<given-names>Pyung-Lim</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Brain and Cognitive Sciences, Ewha Womans University, Seoul 03760, <country>Korea</country>.</aff>
<aff id="A2"><label>2</label>Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, <country>Korea</country>.</aff>
<author-notes>
<corresp>To whom correspondence should be addressed. TEL: +82-2-3277-4130, FAX: +82-2-3277-3419, <email>plhan@ewha.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>28</volume>
<issue>3</issue>
<fpage>337</fpage>
<lpage>351</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © Experimental Neurobiology 2019.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Experimental Neurobiology</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>A number of specific genetic variants including gene mutations and single nucleotide variations have been identified in genomewide association studies of autism spectrum disorder (ASD). ASD phenotypes in individuals carrying specific genetic variations are manifest mostly in a heterozygous state. Furthermore, individuals with most genetic variants show incomplete penetrance and phenotypic variability, suggesting that non-genetic factors are also involved in developing ASD. However, the mechanisms of how genetic and environmental factors interactively promote ASD are not clearly understood. In the present study, we investigated whether early-life stress (ELS) in D2 dopamine receptor heterozygous knockout (D2<sup>+/−</sup>) mice induces ASD-like symptoms. To address that, we exposed D2 heterozygous pups to maternal separation stress for 3 h daily for 13 days beginning on postnatal day 2. D2<sup>+/−</sup> adult mice that had experienced ELS exhibited impaired sociability in the three-chamber test and home-cage social interaction test and increased grooming behavior, whereas wildtype littermates exposed to ELS did not show those phenotypes. ELS-exposed D2<sup>+/−</sup> mice had decreased levels of BDNF, TrkB, phospho-ERK1/2 and phospho-CREB in the dorsal striatum. Administration of the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) to ELS-exposed D2<sup>+/−</sup> mice rescued the sociability deficits and repetitive behavior. In contrast, behavioral rescue by 7,8-DHF in ELS-exposed D2<sup>+/−</sup> mice was blocked when TrkB expression in the dorsal striatum was locally inhibited by the injection of TrkB-siRNA. Together, our results suggest that the interaction between ELS and defective D2 gene function promotes autistic-like behaviors by downregulating the BDNF-TrkB pathway in the dorsal striatum.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<graphic orientation="portrait" position="float" xlink:href="en-28-337-ab001.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>Autism spectrum disorder</kwd>
<kwd>early-life stress</kwd>
<kwd>dorsal striatum</kwd>
<kwd>dopamine receptors</kwd>
<kwd>TrkB receptor</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Korea Health Industry Development Institute</institution>
<institution-id institution-id-type="CrossRef">https://doi.org/10.13039/501100003710</institution-id>
</institution-wrap>
</funding-source>
<award-id>HI15C1834</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Ministry of Science, ICT and Future Planning</institution>
<institution-id institution-id-type="CrossRef">https://doi.org/10.13039/501100003621</institution-id>
</institution-wrap>
</funding-source>
<award-id>2018R1A2B2001535</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by social communication defects and stereotyped repetitive behaviors [<xref ref-type="bibr" rid="B1">1</xref>]. ASD is usually diagnosed before the age of three [<xref ref-type="bibr" rid="B2">2</xref>]. Recent genome-wide studies have identified a number of specific gene mutations in individuals with ASD, including deletion, duplication and point mutations, and genetic variants such as single nucleotide variants and copy number variants. However, phenotypic penetrance of those genetic variants is incomplete [<xref ref-type="bibr" rid="B3">3</xref>]. For example, ASD symptoms are expressed in 84% of cases carrying 22q13.33 deletion or <italic>SHANK3</italic> mutations [<xref ref-type="bibr" rid="B4">4</xref>], 30~60% of cases carrying <italic>NRXN1</italic> deletion [<xref ref-type="bibr" rid="B5">5</xref>], and 24% of cases carrying 16p11.2 deletion and duplication [<xref ref-type="bibr" rid="B6">6</xref><xref ref-type="bibr" rid="B7">7</xref>]. Furthermore, the phenotypic spectrums of the individuals with those genetic variants are highly variable [<xref ref-type="bibr" rid="B8">8</xref><xref ref-type="bibr" rid="B9">9</xref>], partly because ASD phenotypes of individuals with those genetic variations are manifested mostly in a heterozygous state. Furthermore, ASD is produced by the interaction between environmental factors and genetic variants (gene×environment interaction) [<xref ref-type="bibr" rid="B10">10</xref><xref ref-type="bibr" rid="B11">11</xref>]. Therefore, understanding the interaction between environmental factors and genetic factors is important. However, the mechanisms by which gene×environment causes ASD are largely unknown.</p>
<p>Early-life stress (ELS) is believed to be one of that environmental factors affect ASD development [<xref ref-type="bibr" rid="B12">12</xref><xref ref-type="bibr" rid="B13">13</xref>]. The development of the brain network is sensitive to early-life adversity, depending on the intensity of the stress, timing of exposure, and genetic factors [<xref ref-type="bibr" rid="B14">14</xref>]. Specifically, a stressful migration after birth increased the risk of ASD along with stress-induced epigenetic changes [<xref ref-type="bibr" rid="B15">15</xref>]. Mothers with aberrant serotonin function (short allele variants of <italic>SLC6A4</italic>, known as an ASD risk gene) responded differently to stress, which increased the risk of ASD and ASD-like symptoms in their children [<xref ref-type="bibr" rid="B16">16</xref>]. <italic>Slc6a4<sup>+/−</sup></italic> mice treated with prenatal stress exhibited impairment in social interaction and an increased embryonic methylation profile [<xref ref-type="bibr" rid="B17">17</xref><xref ref-type="bibr" rid="B18">18</xref>]. Those studies support the notion that ASD can be induced by the interaction between a genetic defect and environmental disturbance during development. However, that hypothesis has not been directly tested.</p>
<p>The dopamine system is closely related to ASD [<xref ref-type="bibr" rid="B19">19</xref><xref ref-type="bibr" rid="B20">20</xref>]. Polymorphisms in D2 dopamine receptors (A1 allele of Taq I; [<xref ref-type="bibr" rid="B21">21</xref>], rs1800498TT; [<xref ref-type="bibr" rid="B22">22</xref>]) and D1 dopamine receptors (rs265981-C and rs4532-A, rs686-T alleles) [<xref ref-type="bibr" rid="B23">23</xref>], and a <italic>de novo</italic> mutation (T356M) in the dopamine transporter [<xref ref-type="bibr" rid="B24">24</xref>] have been reported in ASD. Furthermore, mice whose D1 receptors were overactivated using a D1 receptor agonist (SKF38393) exhibited autistic-like behaviors. Mice lacking D2 dopamine receptors also showed autistic-like behaviors [<xref ref-type="bibr" rid="B20">20</xref>]. These results suggest that the dopamine system, in particular the D1 overactive state, is closely associated with ASD pathology. In contrast, D2 heterozygous mice, which have a hyperactive state of D1 dopamine receptors in comparison, did not exhibit autistic-like behaviors [<xref ref-type="bibr" rid="B20">20</xref>]. Considering that phenotypic penetrance of many specific genetic mutations is often incomplete [<xref ref-type="bibr" rid="B3">3</xref><xref ref-type="bibr" rid="B25">25</xref><xref ref-type="bibr" rid="B26">26</xref>], and ASD phenotypes of individuals carrying a known genetic mutation are highly variable [<xref ref-type="bibr" rid="B8">8</xref><xref ref-type="bibr" rid="B9">9</xref>], it is possible that the D2 heterozygous state might function as a genetic risk factor that promotes ASD under certain environmental condition. However, this possibility has not been carefully tested.</p>
<p>In this study, we investigated whether ELS can cause autistic-like behaviors in D2 heterozygous mice. We found that ELS in D2 heterozygous mice but not in wildtype mice produced autistic-like behaviors through the downregulation of BDNF-TrkB signaling in the dorsal striatum.</p>
</sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec>
<title>Animals</title>
<p>C57BL/6 mice were purchased from Daehan BioLink (Eumsung, Chungbuk, Republic of Korea). D2 dopamine receptor knockout (KO) mice were described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B27">27</xref>]. D2 KO mice were backcrossed to C57BL/6 mice for more than 10 generations. D2 KO mice and their wildtype (WT) littermates used in all experiments were from heterozygote crosses. For genotyping, the following primer sets were used: 5′-TGTGACTGCAACATCCCA CC-3′ and 5′-GCGGAACTCAATGTTGAAGG-3′ for D2 WT (105 bp); 5′-CTTG GGTGGAGAGGCTATTC-3′ and 5′-AGGTGAGATGACAGGA GATC-3′ for D2 KO (neo; 280 bp). The animal room was maintained at a temperature of 22~23℃ with 50~60% humidity and a normal light-dark cycle (light on at 7:00 a.m.) in a specific-pathogen-free environment. All animals were handled in accordance with the Guidelines of Animal Care at Ewha Womans University through the permission granted by EWU-IACUC (No. 16-020).</p>
</sec>
<sec>
<title>Early-life stress (ELS) treatment</title>
<p>ELS treatment was carried out as described previously [<xref ref-type="bibr" rid="B28">28</xref>]. Male D2 heterozygous KO mice were crossed with female C57BL/6 mice. Pregnant females were randomly assigned to one of maternal separation groups and control groups. Two to three days before giving birth, pregnant females were habituated to a signal cage filled with wood particles 30% less than before. The number of pups for each mother was adjusted to have six to eight. The pups were separated from their mother from 9:00 A.M. and placed together in a clean plastic cage maintained at 32~33℃ with 50~60% humidity, and then returned to their mother in the original cage after 3 hours of separation. Maternal separation began on postnatal day 2 and was repeated until postnatal day 14. For the control group, pregnant female were habituated to a single cage with normal wood particles two to three days before giving birth, and the control pups were reared without maternal separation in parallel with the ELS-exposed group. Control and ELS-exposed pups were weaned 4 weeks after birth. After genotyping, they were housed 2~3 mice with the same sex in a regular plastic cage. This housing condition was maintained until the behavioral tests, which was conducted between 8 and 10 weeks after birth.</p>
</sec>
<sec>
<title>Restraint stress treatment</title>
<p>Mice were restrained as described previously [<xref ref-type="bibr" rid="B29">29</xref>]. In brief, mice were individually placed in a 50-ml polypropylene conical tube that have many holes for ventilation and were restrained within this tube for 1 h.</p>
</sec>
<sec>
<title>Corticosterone measurement</title>
<p>Corticosterone measurements were carried out as described previously [<xref ref-type="bibr" rid="B29">29</xref>]. For these experiments, all animals were sacrificed between 12 p.m. and 1 p.m. ELS-exposed pups were sacrificed after the last treatment of maternal separation stress on postnatal day 14. Blood was collected from the hearts of the sacrificed mice. It was centrifuged at 1,500 g for 15 min to obtain serum, which was then stored at −80℃ until use. Plasma corticosterone levels were assessed using a commercial enzyme immunoassay kit (ADI-900-045, Enzo Life Science, NY, USA) and following the manufacturer's instructions. In brief, 1:40 diluted samples were loaded in each well in duplicate and probed with corticosterone ELISA antibody for 2 hours. Then, the wells were emptied, rinsed three times with wash buffer, and probed with pNPP-substrate for 1 hour at room temperature. Optical density was detected at 405nm using a spectrofluorometer (SpectraMax M5, Molecular Devices).</p>
</sec>
<sec>
<title>Stereotaxic injection</title>
<p>Stereotaxic injection of siRNA was carried out as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref><xref ref-type="bibr" rid="B31">31</xref>]. Mice were anesthetized with a mixture of ketamine hydrochloride (50 mg/mL) and xylazine hydrochloride (23.3 mg/ml) at a dose of 2.5 µl per body weight (g). While the mouse head was held in the stereotaxic device (Stoelting Company, Wood Dale, IL, USA), 1.5 µl (18 ng of siRNA) of siRNA mixture per each side of the dorsal striatum (AP, +1.0; ML, ±1.5; DV, −3.6 mm) was injected at the rate of 0.2 µl/min using a 30 G needle. The siRNA mixture was prepared 20 min before injection by mixing 1 µl of control-siRNA or TrkB-siRNA with siGLO Green (1/19 of target gene-siRNA), 0.5 µl of 50% sucrose and 2.5 µl of Neuro-FECT transfection reagent (T800075; Genlantis, San Diego, CA, USA).</p>
<p>Behavioral tests were conducted at the indicated time points. After the behavioral tests, the injection sites were confirmed by a histological analysis, and the mice with the wrong injection site were excluded from the final data as described [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref><xref ref-type="bibr" rid="B31">31</xref>]. The following siRNAs were used: control-siRNA (SN-1012) and Trk-BsiRNA (1393919, NM_001025074.2) were purchased from Bioneer Co. (Deajun, Korea), and FAM-labeled RISK-independent siRNA transfection control siGLO Green (D-001630-01-05) was purchased from Dharmacon Inc. (Chicago, IL, USA).</p>
</sec>
<sec>
<title>Drug administration</title>
<p>7,8-Dihydroxyflavone (7,8-DHF) was intraperitoneally administered once a day for three consecutive days at a dose of 10 mg/kg. The dose was chosen on the basis of a dose test in this study and a previous study [<xref ref-type="bibr" rid="B32">32</xref>]. 7,8-DHF was purchased from Sigma Aldrich (St. Louis, MO, USA).</p>
</sec>
<sec>
<title>Real-time PCR analysis</title>
<p>The real-time PCR analysis was performed as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. Total RNA was extracted from the brain tissues of 3~4 animals from each group using TRI reagent (Sigma-Aldrich, St. Louis, MO, USA) with DNAase I to prevent genomic DNA contamination. Real-time PCR was conducted with iQTM SYBR Green Supermix (Bio-Rad Laboratories, Foster City, CA, USA) using a CFX 96 Real-Time PCR System Detector (Bio-Rad Laboratories; Foster City, CA, USA). The following primer sets were used: 5′-AAGGACTTTCATCGGGAAGCTG-3′ and 5′-TCGCCCTCCACACAGACAC-3′ for <italic>TrkB</italic>; 5′-TGTCGTATTCACCTTCAGTT-3′ and 5′-TGCTTTCAGTCATTTGGCTATA-3′ for <italic>Mecp2</italic>; 5′-CAGTGTGGCTCAGATTCCCT-3′ and 5′-GGGCAGCTCATTAGGGATCT-3′ for <italic>Hdac1</italic>; 5′-GGGACAGGCTTGGTTGTTTC-3′ and 5′-GAGCATCAGCAATGGCAAGT-3′ for <italic>Hdac2</italic>; 5′-AGAGAGGTCCCGAGGAGAAC-3′ and 5′-CTCTTGGGGACACAGCATC-3′ for <italic>Hdac3</italic>; 5′-CAATCCCACAGTCTCCGTGT-3′ and 5′-CAGCACCCCACTAAGGTTCA-3′ for <italic>Hdac4</italic>; 5′-TGTCACCGCCAGATGTTTTG-3′ and 5′-TGAGCAGAGCCGAGACACAG-3′ for <italic>Hdac5</italic>; 5′-TGGCTGACACTTTTGAGCAC-3′ and 5′-GTTTGCGGCATCCAGGTAAT-3′ for <italic>tBdnf</italic>; 5′-CCTGCATCTGTTGGGGAGAC-3′ and 5′-GCCTTGTCCGTGGACGTTTA-3′ for <italic>Bdnf1</italic>; 5′-CAGAGCAGCTGCCTTGATGTT-3′ and 5′-GCCTTGTCCGTGGACGTTTA-3′ for <italic>Bdnf4</italic>; 5′-GCTGCCATCTGTTTTACGG-3′ and 5′-TGACTGGTGCCTGATGAACT-3′ for <italic>Gapdh</italic>; and 5′-GCTGCCATCTGTTTTACGG-3′ and 5′-TGACTGGTGCCTGATGAACT-3′ for <italic>L32</italic>.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>Western blot analyses were performed as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. Brain tissues were homogenized in lysis buffer (50 mM Tris-HCl with pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 0.5% Triton X-100, 0.25% sodium deoxycholate, 0.25% SDS, and 1 mM EDTA) with protease inhibitors (Complete Mini; Roche Applied Science). Protein concentrations were determined using the Bradford method. Proteins, 20 µg per lane, were loaded on SDS-PAGE, and transferred onto a PVDF membrane (Bio Rad., Hercules, CA, USA). Blots were blocked with 3% BSA in 0.1% TBS-T buffer and then probed with a primary antibody for p-ERK1/2 (4370, Cell Signaling Technology, Beverly, MA, USA), ERK1/2 (sc-135900, Santa Cruz Inc., Santa Cruz, CA, USA), p-CREB (06-519, Upstate Biotechnology Inc., Lake Placid, NY, USA), CREB (sc-186, Santa Cruz), MeCP2 (3456, Cell Signaling), TrkB (sc-136990, Santa Cruz), AKT (9272, Cell Signaling), S473-pAKT (9271, Cell Signaling), BDNF (ab108319, abcam), or β-actin (sc-47778, Santa Cruz). The following secondary antibodies were used; goat anti-rabbit IgG (sc-2004, Santa Cruz), goat anti-mouse IgG (sc-2005, Santa Cruz), and donkey anti-goat IgG (sc-2020, Santa Cruz). Specific signals were visualized using an enhanced chemiluminescence system (EBP-10073; Elpis Biotech. Inc., Daejon, Korea), and quantified using ImageJ (NIH, USA).</p>
</sec>
<sec>
<title>Behavioral assessments</title>
<p>Behavioral assessments were carried out using a computerized video tracking system (SMART, Panlab, Spain) as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. The behavior testing room was lit by indirect illumination to 20 lux for the U-field assay, three-chamber test, reciprocal social interaction test, open field test, and repetitive behavior test. White noise (65 dB) was used in the behavior testing room. Behavior test equipment was cleaned frequently using 70% ethanol.</p>
</sec>
<sec>
<title>Three-chamber test</title>
<p>The three-chamber test was carried out as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. The three-chamber apparatus consisted of an open-topped rectangular three-compartmented box (22×32 cm<sup>2</sup> per compartment) made of clear polycarbonate, with two transparent dividing walls containing a retractable pass way in the middle of each wall (10-cm wide) to give the animal access to each chamber. A subject mouse was allowed to freely explore the three chambers, starting from the middle chamber, and the time spent and trajectory in the chambers were recorded for 10 min; this procedure was regarded as habituation. While a habituated subject mouse was in the middle chamber with the pass ways closed, a circular wire cage (12 cm in diameter) containing a social target (a naïve C57BL/6 mouse of the same sex and age as the subject) was placed in one side chamber, and an empty wire cage was placed in the other side chamber. By opening the pass ways, the subject mouse was allowed to freely explore both chambers, and the time spent and trajectory in the chambers, and the time spent sniffing the target mouse were recorded for 10 min.</p>
</sec>
<sec>
<title>Reciprocal social interaction test</title>
<p>The reciprocal social interaction test, also called home-cage social interaction test, was performed as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>] with a minor modification. In brief, subject mice were individually placed in a home cage with new bedding for 20 min as habituation. After habituation, a target mouse (the same age and sex as the subject) that had not been seen before by the subject mouse was placed in the same cage for 10 min, during which the time spent in contact, such as facial and anogenital sniffing or mounting behavior, was recorded and regarded as social behavior.</p>
</sec>
<sec>
<title>Grooming behavior assessment</title>
<p>Grooming behavior assessment was carried out as described previously [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>] with a minor modification. Mice were placed individually in an open field (45×45 cm) and allowed to move freely for 30 min. Grooming behavior was recorded for 15 min in the second half of the open field test. Grooming behavior was defined as rubbing the face, body, or head with the two forelimbs.</p>
</sec>
<sec>
<title>Open field test</title>
<p>The open field test was performed as described previously [<xref ref-type="bibr" rid="B30">30</xref><xref ref-type="bibr" rid="B33">33</xref>]. Mice were placed individually in the open field (45×45 cm) and allowed to move freely for 30 min. The distance and trajectory of locomotion in the open field was recorded.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Two-sample comparisons were performed using the Student's t-test, and multiple comparisons were performed using one-way and two-way ANOVA or two-way repeated measures ANOVA followed by a post hoc test. Statistical analyses were carried out using GraphPad Prism 6 (San Diego, CA, USA). All data are presented as mean±SEM or box plot diagrams, and statistical significance was accepted at the 5% level.</p>
</sec>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>ELS in D2 heterozygous KO mice produced sociability deficits and stereotyped behavior</title>
<p>Maternal separation was chosen as the ELS with pups separated from their mothers for 3 hours per day from postnatal day 2 to postnatal day 14. (<xref ref-type="fig" rid="F1">Fig. 1A and 1B</xref>). Wild-type (WT) mice exposed to ELS showed social interaction levels comparable to those of the normally raised WT mice in the three-chamber test (<xref ref-type="fig" rid="F1">Fig. 1C and 1D</xref>). Normally raised D2<sup>+/−</sup> mice exhibited WT-like social interaction, whereas ELS-exposed D2<sup>+/−</sup> mice showed decreased social interaction in the three-chamber test (<xref ref-type="fig" rid="F1">Fig. 1C and 1E</xref>). Sniffing time with a social target during the three-chamber test was also decreased in ELS-exposed D2<sup>+/−</sup> mice (<xref ref-type="fig" rid="F1">Fig. 1F</xref>). In the home-cage social interaction test, ELS-exposed D2<sup>+/−</sup> mice, but not other groups, showed less social interaction time than WT control mice with a newly introduced social target (<xref ref-type="fig" rid="F1">Fig. 1G</xref>). ELS-exposed D2<sup>+/−</sup> mice also exhibited increased grooming in the open field without changes in locomotion (<xref ref-type="fig" rid="F1">Fig. 1H and 1I</xref>). These results suggest that ELS causes autistic-like behaviors in D2 heterozygous mice but not in WT mice.</p>
</sec>
<sec>
<title>D2 heterozygous pups had altered hypothalamus-pituitary-adrenal gland (HPA) axis responses to early-life stress</title>
<p>We examined whether the behavioral abnormalities of ELS-exposed D2<sup>+/−</sup> mice were associated with HPA axis dysfunction. At the end of their last 3-h maternal separation at postnatal day 14, WT pups exhibited corticosterone levels that were insignificantly increased compared with normally raised WT pups. In contrast, ELS-exposed D2 heterozygous pups exhibited significantly increased corticosterone levels at the end of their last 3-h maternal separation (<xref ref-type="fig" rid="F2">Fig. 2A and 2B</xref>).</p>
<p>Adult D2<sup>+/−</sup> mice raised normally had basal corticosterone levels similar to those of adult WT mice raised normally. ELS-exposed adult WT mice and D2<sup>+/−</sup> mice also showed similar levels of basal corticosterone. When exposed to 60-min restraint, ELS-exposed adult WT mice had markedly increased corticosterone levels, and ELS-exposed adult D2<sup>+/−</sup> mice also had increased corticosterone levels, but the increase caused by acute stress was slightly lower in the ELS-exposed adult D2<sup>+/−</sup> mice than in ELS-exposed adult WT mice (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). These results suggest that D2 heterozygous pups had higher activation of the HPA axis in response to maternal separation stress than wildtype littermate, and when ELS-exposed D2 heterozygous mice grew up, they had reduced HPA axis activation to restraint challenge compared to wildtype mice.</p>
</sec>
<sec>
<title>D2 heterozygous KO mice exposed to ELS had reduced expression of neurotrophic factors in the dorsal striatum</title>
<p>Brain-derived neurotrophic factor (BDNF) is associated with childhood maltreatment [<xref ref-type="bibr" rid="B34">34</xref>], autism [<xref ref-type="bibr" rid="B35">35</xref><xref ref-type="bibr" rid="B36">36</xref><xref ref-type="bibr" rid="B37">37</xref>] and ELS induced molecular changes [<xref ref-type="bibr" rid="B34">34</xref>]. Early-life adversity induces gene transcription alterations that last throughout the lifetime via epigenetic factors [<xref ref-type="bibr" rid="B38">38</xref>]. Therefore, we examined whether ELS exposure changed the expression levels of neurotrophic factors, TrkB, and key epigenetic factors known to regulate neurotrophic factors. Recent studies suggest that the dorsal striatum was the neural substrate whose dysfunction produced sociability deficits and grooming behaviors, the two core domains of ASD symptoms [<xref ref-type="bibr" rid="B19">19</xref><xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. Furthermore, siRNA-mediated knockdown of D2 receptor in the dorsal striatum was sufficient to produce autistic-like behaviors [<xref ref-type="bibr" rid="B20">20</xref>]. Therefore, we focused on the molecular changes in the dorsal striatum in following experiments (<xref ref-type="fig" rid="F3">Fig. 3A</xref>).</p>
<p>Real-time PCR analysis indicated that <italic>TrkB</italic> expression was decreased in the dorsal striatum of ELS-exposed D2<sup>+/−</sup> pups, but not ELS-exposed WT pups, at the end of ELS on postnatal day 14, and total <italic>Bdnf</italic> (<italic>tBdnf</italic>), <italic>Bdnf1</italic>, and <italic>Bdnf4</italic> transcript levels also tended to decrease only in ELS-exposed D2<sup>+/−</sup> pups (<xref ref-type="fig" rid="F3">Fig. 3B and 3C</xref>).</p>
<p>The transcript levels of <italic>TrkB</italic>, <italic>tBdnf</italic>, and <italic>Bdnf4</italic> were reduced in the dorsal striatum of ELS-exposed adult D<sup>+/−</sup> mice but not in ELS-exposed adult WT mice (<xref ref-type="fig" rid="F3">Fig. 3D</xref>). The transcript levels of <italic>Mecp2</italic>, <italic>Hdac2</italic>, and <italic>Hdac3</italic> were also reduced in the dorsal striatum of ELS-exposed adult D2<sup>+/−</sup> mice but not in ELS-exposed adult WT mice (<xref ref-type="fig" rid="F3">Fig. 3E</xref>).</p>
<p>Western blot analysis indicated that the protein levels of TrkB, BDNF, and MeCP2 were decreased in the dorsal striatum of ELS-exposed adult D2<sup>+/−</sup> mice but not in ELS-exposed adult WT mice (<xref ref-type="fig" rid="F3">Fig. 3F and 3G</xref>). Furthermore, the protein levels of p-AKT, p-ERK1/2, and p-CREB, the downstream factors of TrkB receptors, tended to decrease in ELS-exposed D2<sup>+/−</sup> mice (<xref ref-type="fig" rid="F3">Fig. 3H and 3I</xref>). These results suggest that early-life stress in D2 heterozygous pups resulted in the altered expression of factors in the BDNF-TrkB signaling system in the dorsal striatum of adult animals.</p>
</sec>
<sec>
<title>7,8-DHF treatment suppressed autistic-like behaviors of ELS-exposed D2 heterozygous KO mice</title>
<p>The therapeutic effects of TrkB receptor activation have been studied for the treatment of cognitive defects in a mouse model of Alzheimer's disease [<xref ref-type="bibr" rid="B39">39</xref>], Rett syndrome [<xref ref-type="bibr" rid="B40">40</xref>], and ASD [<xref ref-type="bibr" rid="B32">32</xref>]. 7,8-dihydroxyflavone (7,8-DHF) is a naturally occurring flavone that has a neurotrophic activity specific to TrkB [<xref ref-type="bibr" rid="B41">41</xref>]. ELS-exposed D2<sup>+/−</sup> mice and their WT controls were intraperitoneally injected with 7,8-DHF for 3 days, and their behavioral performance was examined 24 hours after the last drug injection (<xref ref-type="fig" rid="F4">Fig. 4A</xref>). 7,8-DHF treatment in WT mice produced no significant change in social interaction in the three-chamber test. In contrast, 7,8-DHF treatment in ELS-exposed D2<sup>+/−</sup> mice increased social interaction in the three-chamber test (<xref ref-type="fig" rid="F4">Fig. 4B and 4C</xref>) and tended to improve defective sociability in the home-cage social interaction test (<xref ref-type="fig" rid="F4">Fig. 4D</xref>). 7,8-DHF treatment in ELS-exposed D2<sup>+/−</sup> mice also suppressed increased grooming to the level seen in WT controls (<xref ref-type="fig" rid="F4">Fig. 4E</xref>).</p>
<p>Next, we examined whether the TrkB agonist also produced molecular restoration in the dorsal striatum. Real-time PCR analysis indicated that the decreased expression of <italic>TrkB</italic>, <italic>Bdnf</italic>, <italic>Bdnf4</italic>, <italic>Mecp2</italic>, and <italic>Hdac2</italic> transcripts in the dorsal striatum of ELS-exposed D2<sup>+/−</sup> mice was reversed to WT levels by 7,8-DHF treatment. In particular, the total <italic>Bdnf</italic> transcript level was dramatically elevated in ELS-exposed D2<sup>+/−</sup> mice after 7,8-DHF treatment (<xref ref-type="fig" rid="F4">Fig. 4F</xref>). Protein levels of TrkB and BDNF were increased by 7,8-DHF treatment in normally raised WT mice, although their expression levels in ELS-exposed D2<sup>+/−</sup> mice did not significantly increase (<xref ref-type="fig" rid="F4">Fig. 4G and 4H</xref>). 7,8-DHF treatment in ELS-exposed D2<sup>+/−</sup> mice tended to restore the reduced level of p-AKT and p-ERK1/2 in the dorsal striatum, although its effect was not significant (<xref ref-type="fig" rid="F4">Fig. 4I and 4J</xref>). These results suggest that 7,8-DHF treatment rescued the autistic-like behaviors of ELS-exposed D2<sup>+/−</sup> mice and weakly changed the TrkB and BDNF signaling system in the dorsal striatum.</p>
</sec>
<sec>
<title>Inhibition of TrkB in the dorsal striatum blocked the behavioral effects of 7,8-DHF treatment in ELS-exposed D2<sup>+/−</sup> mice</title>
<p>Next, we examined whether the behavioral effects of 7,8-DHF treatment were produced through the activation of TrkB in the dorsal striatum. To address that, we stereotaxically injected TrkB-siRNA or control-siRNA into the dorsal striatum on both sides, followed by 7,8-DHF injection for 3 days. The behavioral tests were performed on the day after the last 7,8-DHF injection (<xref ref-type="fig" rid="F5">Fig. 5A</xref>). These experiments were verified that the siRNA-mediated knockdown of TrkB in the dorsal striatum reduced the expression levels of TrkB, p-AKT and p-ERK1/2 for more than 3 days (<xref ref-type="fig" rid="F5">Fig. 5B and 5C</xref>), which is consistent with previous reports [<xref ref-type="bibr" rid="B42">42</xref><xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>Normally raised WT mice injected with TrkB-siRNA did not show behavioral changes compared with WT mice injected with control-siRNA. ELS-exposed D2<sup>+/−</sup> mice injected with control-siRNA and treated with 7,8-DHF showed increased sociability in the three-chamber test and the home-cage social interaction test. In contrast, ELS-exposed D2<sup>+/−</sup> mice injected with TrkB-siRNA and treated with 7,8-DHF exhibited social deficits in the three-chamber test (<xref ref-type="fig" rid="F5">Fig. 5D</xref>). TrkB-siRNA injection in ELS-exposed D2<sup>+/−</sup> mice also partially blocked the effects of 7,8-DHF on sociability in the home-cage social interaction test (<xref ref-type="fig" rid="F5">Fig. 5E</xref>). Regarding grooming behavior, TrkB-siRNA injection did not clearly block the effects of 7,8-DHF in ELS-exposed D2<sup>+/−</sup> mice (<xref ref-type="fig" rid="F5">Fig. 5F</xref>). Together, these results suggest that TrkB-related changes in the dorsal striatum are critical to the behavioral effects of 7,8-DHF treatment in ELS-exposed D2<sup>+/−</sup> mice.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<sec>
<title>Early-life stress promoted autistic-like behaviors in D2 heterozygous KO mice but not WT mice</title>
<p>This study demonstrates that ELS produced sociability deficits and increased grooming behavior, the behavioral phenotypes relevant to the two core domains of ASD symptoms, in D2<sup>+/−</sup> mice but not WT mice (<xref ref-type="fig" rid="F1">Fig. 1</xref>). D2 homozygous KO mice exhibited typical autistic-like behaviors [<xref ref-type="bibr" rid="B20">20</xref>], and when exposed to chronic stress, they showed severe depressive-like behaviors [<xref ref-type="bibr" rid="B44">44</xref>]. In contrast, D2 heterozygous KO mice did not show autistic-like behaviors (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Therefore, the autistic-like phenotypes displayed by ELS-exposed D2<sup>+/−</sup> adult mice likely resulted from the gene×stress interaction imposed during the early developing period. We have provided evidence that D2<sup>+/−</sup> pups had much higher activation of the HPA axis in response to ELS compared with WT pups exposed to ELS (<xref ref-type="fig" rid="F2">Fig. 2</xref>). The increased stress response in D2<sup>+/−</sup> pups was correlated with the reduced expression of TrkB and BDNF in the dorsal striatum (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). Furthermore, expression levels of <italic>TrkB</italic>, <italic>Bdnf</italic>, <italic>Mecp2</italic> and <italic>Hdac2</italic> transcripts were reduced in the dorsal striatum of ELS-exposed D2<sup>+/−</sup> mice but not in the dorsal striatum of normally raised D2<sup>+/−</sup> mice (<xref ref-type="fig" rid="F3">Fig. 3D and 3E</xref>). Although the detailed mechanism of how such changes cause ASD-like behaviors need to be studied in the future, our results suggest that ELS in animals with defective dopamine receptor function causes to the development of ASD-like phenotypes.</p>
<p>In developing pups, the HPA axis functionally reacts to stressors starting from the second postnatal week. During the first postnatal week, pups have low basal levels of corticosterone, and the levels of corticosterone and ACTH start to increase in response to stressors from postnatal day 12 but not at postnatal day 9 [<xref ref-type="bibr" rid="B45">45</xref><xref ref-type="bibr" rid="B46">46</xref>]. Therefore, it is possible that the ELS given to the pups from the middle of the second postnatal week might have induced corticosterone release. It will be necessary to investigate whether the promotion of ASD-like phenotypes in D2<sup>+/−</sup> mice exposed to ELS is caused primarily by increased corticosterone release or some other mechanism.</p>
</sec>
<sec>
<title>Striatal dysfunction induced by genetic and environmental factors promoted autistic-like behaviors</title>
<p>Recently, our lab and others' have reported that the dorsal striatum is the neuroanatomical correlate for ASD core symptoms [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref><xref ref-type="bibr" rid="B47">47</xref>]. Excessive activation of D1 receptors in the dorsal striatum promoted social deficits and repetitive behaviors [<xref ref-type="bibr" rid="B20">20</xref>]. AC5<sup>−/−</sup> and D2<sup>−/−</sup> mice show typical autistic-like behaviors, and siRNA-mediated knockdown of AC5 or D2 receptors within the dorsal striatum was sufficient to replicate autistic-like phenotypes [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B30">30</xref>]. Striatal dysfunction of SHANK3 [<xref ref-type="bibr" rid="B48">48</xref>], TSC1 [<xref ref-type="bibr" rid="B49">49</xref>], MeCP2 [<xref ref-type="bibr" rid="B50">50</xref>], FOXP1 [<xref ref-type="bibr" rid="B51">51</xref>], CNTNAP2 [<xref ref-type="bibr" rid="B52">52</xref>], and DGLα [<xref ref-type="bibr" rid="B53">53</xref>] also produced autistic-like behaviors. A polymorphism of D3 dopamine receptors (rs167771) was correlated with greater caudate nucleus volume and stereo-typed behavior [<xref ref-type="bibr" rid="B54">54</xref>]. Furthermore, specific knockout of MeCP2 or TSC1 in the dorsal striatum produced social deficits and repetitive behavior [<xref ref-type="bibr" rid="B31">31</xref>]. As demonstrated in the present study, repeated ELS in D2 heterozygous pups caused autistic-like behaviors through changes in the BDNF-TrkB signaling pathway in the dorsal striatum (<xref ref-type="fig" rid="F3">Fig. 3</xref>, <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref>). Thus, specific mutations in the genes that function in the dorsal striatum or stress-induced TrkB-dependent changes in the dorsal stratum apparently promote autistic-like behaviors.</p>
</sec>
<sec>
<title>Stimulation of TrkB in the dorsal striatum was required for behavioral effects of 7,8-DHF</title>
<p>Recently, <italic>de novo</italic> mutations in TrkB were identified in individuals with ASD [<xref ref-type="bibr" rid="B55">55</xref>]. Abnormal BDNF levels in the cortex [<xref ref-type="bibr" rid="B37">37</xref>], hippocampus [<xref ref-type="bibr" rid="B37">37</xref>], striatum [<xref ref-type="bibr" rid="B35">35</xref><xref ref-type="bibr" rid="B36">36</xref>], and serum [<xref ref-type="bibr" rid="B56">56</xref>] were reported in ASD. The results of those studies suggest that the BDNF and TrkB receptor system correlates with ASD. ELS-exposed D2<sup>+/−</sup> mice exhibited autistic-like behaviors through reduced expression of BDNF and TrkB in the dorsal striatum, whereas 7,8-DHF treatment notably rescued the autistic-like phenotypes of ELS-exposed D2<sup>+/−</sup> mice (<xref ref-type="fig" rid="F3">Fig. 3</xref>, <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref>). Our results suggest that the BDNF and TrkB system in the dorsal striatum is critical for the development of ASD core symptoms. Consistent with this interpretation, viral vector-mediated expression of BDNF in the dorsal striatum mitigated autistic-like behaviors in <italic>Mecp2</italic> KO mice [<xref ref-type="bibr" rid="B57">57</xref>].</p>
<p>The increase of total <italic>Bdnf</italic> transcript level in ELS-exposed D2<sup>+/−</sup> mice following treatment with 7,8-DHF (<xref ref-type="fig" rid="F4">Fig. 4F</xref>) was only partially manifested by BDNF protein level (<xref ref-type="fig" rid="F4">Fig. 4G and 4H</xref>). The <italic>Bdnf</italic> transcription is regulated by various transcription factors that act at different promoter regions of the <italic>Bdnf</italic> gene in a different signaling context [<xref ref-type="bibr" rid="B58">58</xref>]. Furthermore, TrkB activation increases BDNF expression in a cell autonomous and non-autonomous manner [<xref ref-type="bibr" rid="B39">39</xref><xref ref-type="bibr" rid="B57">57</xref><xref ref-type="bibr" rid="B59">59</xref><xref ref-type="bibr" rid="B60">60</xref>]. TrkB activation by BDNF in rat primary cortical culture produced a biphasic expression of <italic>Bdnf</italic> exon IV~IX mRNA, with the primary induction 1~3 h after TrkB stimulation and the delayed and protracted induction 24~72 hours after the stimulation, in which the early induction was much higher than the delayed induction [<xref ref-type="bibr" rid="B61">61</xref>], thus suggesting that the expression of <italic>Bdnf</italic> exon IV~IX mRNA occurs in a complex time course. TrkB-dependent BDNF expression is regulated by cAMP response element binding protein (CREB) [<xref ref-type="bibr" rid="B62">62</xref>] and Methyl-CpG binding protein 2 (MeCP2) [<xref ref-type="bibr" rid="B63">63</xref><xref ref-type="bibr" rid="B64">64</xref>]. TrkB activation also increases TrkB expression via CREB activation [<xref ref-type="bibr" rid="B59">59</xref><xref ref-type="bibr" rid="B65">65</xref>]. When 7,8-DHF was treated for 3 days, the transcription mechanisms of the <italic>Bdnf</italic> transcription system might be presented into partially mismatched BDNF protein levels (<xref ref-type="fig" rid="F4">Fig. 4G and 4H</xref>), although the underlying mechanisms need to be elaborated.</p>
<p>BDNF expression is regulated by multiple factors, including CREB, MeCP2, and HDACs [<xref ref-type="bibr" rid="B64">64</xref><xref ref-type="bibr" rid="B66">66</xref>]. Furthermore, genetic deficits of <italic>Mecp2</italic>, <italic>Hdac1</italic>, and <italic>Hdac2</italic> in the dorsal striatum produced grooming behavior [<xref ref-type="bibr" rid="B67">67</xref>]. ELS-exposed D2<sup>+/−</sup> mice showed reduced expression of <italic>Mecp2</italic>, and <italic>Hdac2</italic> transcripts in the dorsal striatum, and 7,8-DHF treatment partially reversed those changes (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Regarding these results, it might be worth investigating whether reduced expression of MeCP2 and HDAC2 is responsible for the downregulation of BDNF and TrkB in the dorsal striatum of ELS-exposed D2<sup>+/−</sup> mice. TrkB receptor activation promotes cell autocrine responses in the growth and differentiation of neurons [<xref ref-type="bibr" rid="B57">57</xref><xref ref-type="bibr" rid="B68">68</xref>]. It is also possible that 7,8-DHF treatment afforded behavioral rescue through the increased expression of MeCP2 and HDAC2, which enhanced BDNF and TrkB-dependent autocrine signaling in the dorsal striatum, although direct evidence for those links is unavailable.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>This research was supported by a grant (HI15C1834) from the Ministry of Health and Welfare, and a grant (2018R1A2B2001535) from the Ministry of Science, ICT and Future Planning, Republic of Korea.</p>
</ack>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="book">
<collab>American Psychiatric Association</collab>
<source/>Diagnostic and statistical manual of mental disorders
          <edition>5th ed</edition>
<publisher-loc>American Psychiatric Publishing</publisher-loc>
<publisher-name>Washington, D.C.</publisher-name>
<year>2013</year>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiCicco-Bloom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dager</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>The developmental neurobiology of autism spectrum disorder</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<fpage>6897</fpage>
<lpage>6906</lpage>
<pub-id pub-id-type="pmid">16807320</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Advances in autism genetics: on the threshold of a new neurobiology</article-title>
<source/>Nat Rev Genet
          <year>2008</year>
<volume>9</volume>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">18414403</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders</article-title>
<source/>Mol Autism
          <year>2013</year>
<volume>4</volume>
<fpage>17</fpage>
<pub-id pub-id-type="pmid">23758743</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Shehhi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Forman</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>McInerney</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krawczyk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Betts</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Ardle</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gorman</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families</article-title>
<source/>Eur J Med Genet
          <year>2019</year>
<volume>62</volume>
<fpage>204</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">30031152</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinawi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Craigen</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Pursley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Proud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stocco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Kozel</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Sparagana</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>McGrew</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kurczynski</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Savage</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size</article-title>
<source/>J Med Genet
          <year>2010</year>
<volume>47</volume>
<fpage>332</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="pmid">19914906</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Angelo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lebon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Martin-Brevet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Hippolyte</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maillard</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Faucett</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Macé</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chawner</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>David</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Andrieux</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aylward</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Baujat</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Caldeira</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Conus</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Forzano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gérard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goin-Kochel</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Isidor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jacquette</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jønch</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Le Caignec</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Männik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Metspalu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mignot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Passeggeri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rooryck-Thambo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Steinman</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Tjernagel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van Haelst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Draganski</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sherr</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>van den Bree</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Spiro</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Reymond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacquemont</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>WK</given-names>
</name>
</person-group>
<collab>Cardiff University Experiences of Children With Copy Number Variants (ECHO) Study</collab>
<collab>16p11.2 European Consortium</collab>
<collab>Simons Variation in Individuals Project (VIP) Consortium</collab>
<article-title>Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities</article-title>
<source/>JAMA Psychiatry
          <year>2016</year>
<volume>73</volume>
<fpage>20</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">26629640</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merikangas</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Segurado</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corvin</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The phenotypic manifestations of rare genic CNVs in autism spectrum disorder</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>1366</fpage>
<lpage>1372</lpage>
<pub-id pub-id-type="pmid">25421404</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Polyak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mannik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McCready</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pichon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Le Caignec</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van Dijck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Voorhoeve</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Pazuchanics</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kember</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Curró</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castiglia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Galesi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Avola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mattina</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mandarà</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nizon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mercier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bénéteau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blesson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martin-Coignard</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mosca-Boidron</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Caberg</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Bucan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zeesman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nowaczyk</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Faivre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Callier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Perrine</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Prontera</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marle</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Renieri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reymond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kooy</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Isidor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sistermans</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Andrieux</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants</article-title>
<source/>Genet Med
          <year>2019</year>
<volume>21</volume>
<fpage>816</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="pmid">30190612</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rice</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Barone</surname>
<given-names>S</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</article-title>
<source/> Environ Health Perspect
          <year>2000</year>
<issue>108 Suppl 3</issue>
<fpage>511</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="pmid">10852851</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Torigoe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fedele</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lotspeich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ozonoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lajonchere</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Risch</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Genetic heritability and shared environmental factors among twin pairs with autism</article-title>
<source/>Arch Gen Psychiatry
          <year>2011</year>
<volume>68</volume>
<fpage>1095</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="pmid">21727249</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabrucker</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Environmental factors in autism</article-title>
<source/>Front Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>118</fpage>
<pub-id pub-id-type="pmid">23346059</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singletary</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>An integrative model of autism spectrum disorder: ASD as a neurobiological disorder of experienced environmental deprivation, early life stress and allostatic overload</article-title>
<source/>Neuropsychoanalysis
          <year>2015</year>
<volume>2</volume>
<fpage>81</fpage>
<lpage>119</lpage>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Stress and the social brain: behavioural effects and neurobiological mechanisms</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<fpage>290</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="pmid">25891510</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crafa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Warfa</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Maternal migration and autism risk: systematic analysis</article-title>
<source/>Int Rev Psychiatry
          <year>2015</year>
<volume>27</volume>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">25738316</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hecht</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Tilley</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Beversdorf</surname>
<given-names>DQ</given-names>
</name>
</person-group>
<article-title>Maternal serotonin transporter genotype affects risk for ASD with exposure to prenatal stress</article-title>
<source/>Autism Res
          <year>2016</year>
<volume>9</volume>
<fpage>1151</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="pmid">27091118</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Givens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tilley</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Beversdorf</surname>
<given-names>DQ</given-names>
</name>
</person-group>
<article-title>Combined effect of maternal serotonin transporter genotype and prenatal stress in modulating offspring social interaction in mice</article-title>
<source/>Int J Dev Neurosci
          <year>2010</year>
<volume>28</volume>
<fpage>529</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="pmid">20470877</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sjaarda</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McNaughton</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Will</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ayub</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Beversdorf</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>8735</fpage>
<pub-id pub-id-type="pmid">28821725</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavăl</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A dopamine hypothesis of autism spectrum disorder</article-title>
<source/>Dev Neurosci
          <year>2017</year>
<volume>39</volume>
<fpage>355</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">28750400</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Excessive D1 dopamine receptor activation in the dorsal striatum promotes autistic-like behaviors</article-title>
<source/>Mol Neurobiol
          <year>2018</year>
<volume>55</volume>
<fpage>5658</fpage>
<lpage>5671</lpage>
<pub-id pub-id-type="pmid">29027111</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comings</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Comings</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Muhleman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shahbahrami</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tast</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Knell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kocsis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Baumgarten</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Borison</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>MacMurray</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tosk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sverd</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gysin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Flanagan</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders</article-title>
<source/>JAMA
          <year>1991</year>
<volume>266</volume>
<fpage>1793</fpage>
<lpage>1800</lpage>
<pub-id pub-id-type="pmid">1832466</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hettinger</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>Michaelis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families</article-title>
<source/>Behav Brain Funct
          <year>2012</year>
<volume>8</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">22559203</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hettinger</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Michaelis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2008</year>
<volume>147B</volume>
<fpage>628</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="pmid">18205172</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Erreger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Herborg Hansen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Belovich</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Sahai</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Gether</surname>
<given-names>U</given-names>
</name>
<name>
<surname>McHaourab</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Matthies</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>A</given-names>
</name>
</person-group>
<collab>NIH ARRA Autism Sequencing Consortium</collab>
<article-title><italic>De novo</italic> mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<fpage>1315</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="pmid">23979605</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ijichi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ijichi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ijichi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sameshima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morioka</surname>
<given-names>H</given-names>
</name>
</person-group>
<chapter-title>The genetic basis of phenotypic diversity: autism as an extreme tail of a complex dimensional trait</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Deutsch</surname>
<given-names>S</given-names>
</name>
</person-group>
<source/>Autism spectrum disorders: the role of genetics in diagnosis and treatment
          <publisher-loc>Rijeka</publisher-loc>
<publisher-name>InTech</publisher-name>
<year>2011</year>
<fpage>83</fpage>
<lpage>102</lpage>
<comment></comment>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Krawczak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Polychronakos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tyler-Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kehrer-Sawatzki</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease</article-title>
<source/>Hum Genet
          <year>2013</year>
<volume>132</volume>
<fpage>1077</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="pmid">23820649</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asa</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Saez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bunzow</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Hnasko</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ben-Jonathan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grandy</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice</article-title>
<source/>Neuron
          <year>1997</year>
<volume>19</volume>
<fpage>103</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="pmid">9247267</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Funato</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hobara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Otsuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<fpage>15007</fpage>
<lpage>15018</lpage>
<pub-id pub-id-type="pmid">21068306</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Physical exercise counteracts stress-induced upregulation of melanin-concentrating hormone in the brain and stress-induced persisting anxiety-like behaviors</article-title>
<source/>Exp Neurobiol
          <year>2016</year>
<volume>25</volume>
<fpage>163</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="pmid">27574483</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Loss of adenylyl cyclase type-5 in the dorsal striatum produces autistic-like behaviors</article-title>
<source/>Mol Neurobiol
          <year>2017</year>
<volume>54</volume>
<fpage>7994</fpage>
<lpage>8008</lpage>
<pub-id pub-id-type="pmid">27878759</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Striatal inhibition of MeCP2 or TSC1 produces sociability deficits and repetitive behaviors</article-title>
<source/>Exp Neurobiol
          <year>2018</year>
<volume>27</volume>
<fpage>539</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="pmid">30636904</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KT</given-names>
</name>
</person-group>
<article-title>Autism-like behavior caused by deletion of vaccinia-related kinase 3 is improved by TrkB stimulation</article-title>
<source/>J Exp Med
          <year>2017</year>
<volume>214</volume>
<fpage>2947</fpage>
<lpage>2966</lpage>
<pub-id pub-id-type="pmid">28899869</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Chronic antidepressant treatment in normal mice induces anxiety and impairs stress-coping ability</article-title>
<source/>Exp Neurobiol
          <year>2015</year>
<volume>24</volume>
<fpage>156</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">26113795</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Lubin</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Funk</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Lasting epigenetic influence of early-life adversity on the BDNF gene</article-title>
<source/>Biol Psychiatry
          <year>2009</year>
<volume>65</volume>
<fpage>760</fpage>
<lpage>769</lpage>
<pub-id pub-id-type="pmid">19150054</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deogracias</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yazdani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dekkers</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Guy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ionescu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Barde</surname>
<given-names>YA</given-names>
</name>
</person-group>
<article-title>Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2012</year>
<volume>109</volume>
<fpage>14230</fpage>
<lpage>14235</lpage>
<pub-id pub-id-type="pmid">22891354</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmerle</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ahlbrand</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bronson</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Lundgren</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Richtand</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Seroogy</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation</article-title>
<source/>Schizophr Res
          <year>2015</year>
<volume>168</volume>
<fpage>411</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="pmid">26206493</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boschian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Messina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bozza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castellini</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Provenzano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bozzi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Casarosa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Impaired neuronal differentiation of neural stem cells lacking the engrailed-2 gene</article-title>
<source/>Neuroscience
          <year>2018</year>
<volume>386</volume>
<fpage>137</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">29964155</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroud</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Hrvatin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Greben</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Renthal</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Boxer</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hochbaum</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Kinde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gabel</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Early-life gene expression in neurons modulates lasting epigenetic states</article-title>
<source/>Cell
          <year>2017</year>
<volume>171</volume>
<fpage>1151</fpage>
<lpage>1164.e16</lpage>
<pub-id pub-id-type="pmid">29056337</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease</article-title>
<source/>Neuropsychopharmacology
          <year>2012</year>
<volume>37</volume>
<fpage>434</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="pmid">21900882</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmid</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ogier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mirakhur</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Massa</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome</article-title>
<source/>J Neurosci
          <year>2012</year>
<volume>32</volume>
<fpage>1803</fpage>
<lpage>1810</lpage>
<pub-id pub-id-type="pmid">22302819</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yepes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blanchi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>YE</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>2687</fpage>
<lpage>2692</lpage>
<pub-id pub-id-type="pmid">20133810</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Adenylyl cyclase-5 in the dorsal striatum function as a molecular switch for the generation of behavioral preferences for cue-directed food choices</article-title>
<source/>Mol Brain
          <year>2014</year>
<volume>7</volume>
<fpage>77</fpage>
<pub-id pub-id-type="pmid">25378213</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bortolozzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castañé</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Semakova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Santana</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Alvarado</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cortés</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrés-Coy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Carmona</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perales</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Montefeltro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Artigas</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>612</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="pmid">21808255</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Baik</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Role of dopamine D2 receptors in plasticity of stress-induced addictive behaviours</article-title>
<source/>Nat Commun
          <year>2013</year>
<volume>4</volume>
<fpage>1579</fpage>
<pub-id pub-id-type="pmid">23481387</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Enthoven</surname>
<given-names>L</given-names>
</name>
<name>
<surname>van der Mark</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>S</given-names>
</name>
<name>
<surname>de Kloet</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Oitzl</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>The postnatal development of the hypothalamic-pituitary-adrenal axis in the mouse</article-title>
<source/>Int J Dev Neurosci
          <year>2003</year>
<volume>21</volume>
<fpage>125</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="pmid">12711350</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dent</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Okimoto</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Stress-induced alterations in corticotropin-releasing hormone and vasopressin gene expression in the paraventricular nucleus during ontogeny</article-title>
<source/>Neuroendocrinology
          <year>2000</year>
<volume>71</volume>
<fpage>333</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">10878495</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuccillo</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Striatal circuits as a common node for autism pathophysiology</article-title>
<source/>Front Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>27</fpage>
<pub-id pub-id-type="pmid">26903795</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peça</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Venkatraman</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Lascola</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>
<source/>Nature
          <year>2011</year>
<volume>472</volume>
<fpage>437</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">21423165</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benthall</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Bateup</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Corticostriatal transmission is selectively enhanced in striatonigral neurons with postnatal loss of Tsc1</article-title>
<source/>Cell Reports
          <year>2018</year>
<volume>23</volume>
<fpage>3197</fpage>
<lpage>3208</lpage>
<pub-id pub-id-type="pmid">29898392</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Samaco</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Neul</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ekker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rosenmund</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>
<source/>Nature
          <year>2010</year>
<volume>468</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">21068835</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Magueresse</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Froehlich</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sticht</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gluch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Monyer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rappold</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>632</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="pmid">25266127</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peñagarikano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Winden</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Gdalyahu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sonnenblick</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Gruver</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Almajano</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bragin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Golshani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Trachtenberg</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Peles</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits</article-title>
<source/>Cell
          <year>2011</year>
<volume>147</volume>
<fpage>235</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">21962519</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shonesy</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Parrish</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Báldi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bluett</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Centanni</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Folkes</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Spiess</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Augustin</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lovinger</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Winder</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Colbran</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Role of striatal direct pathway 2-arachidonoylglycerol signaling in sociability and repetitive behavior</article-title>
<source/>Biol Psychiatry
          <year>2018</year>
<volume>84</volume>
<fpage>304</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="pmid">29458998</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staal</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Langen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mensen</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Durston</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>DRD3 gene and striatum in autism spectrum disorder</article-title>
<source/>Br J Psychiatry
          <year>2015</year>
<volume>206</volume>
<fpage>431</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">25792691</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Cossette</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lemay</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Laporte</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Nassif</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Diallo</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Monlong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cadieux-Dion</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dobrzeniecka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meloche</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Retterer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Massicotte</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miguet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brunga</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hollingsworth</surname>
<given-names>G</given-names>
</name>
<name>
<surname>FitzPatrick</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Donaldson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Canham</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Shelagh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brittain</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Blyth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lebel</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Gerkes</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Davis-Keppen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Dorison</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Fassi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Corsten-Janssen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kamsteeg</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Mau-Them</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Bruel</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Verloes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Õunap</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wojcik</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Venkateswaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Bizargity</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Leuzzi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dallapiccola</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blumkin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wierenga</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Purcarin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>O'Byrne</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Stockler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lehman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nougues</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Mignot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Auvin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hiatt</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bebin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lalani</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Jarjour</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Riou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Srour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carmant</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lortie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Diadori</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dubeau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>D'Anjou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bourque</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Sadleir</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Campeau</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Kibar</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lafrenière</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Mercimek-Mahmutoglu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boelman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Minassian</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>High rate of recurrent de novo mutations in developmental and epileptic encephalopathies</article-title>
<collab>Deciphering Developmental Disorders Study</collab>
<source/>Am J Hum Genet
          <year>2017</year>
<volume>101</volume>
<fpage>664</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="pmid">29100083</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dougali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sideri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kroupis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vasdekis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Douzenis</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor (BDNF) in children with ASD and their parents: a 3-year follow-up</article-title>
<source/>Acta Psychiatr Scand
          <year>2018</year>
<volume>137</volume>
<fpage>433</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="pmid">29532458</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampathkumar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Vadhvani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trimbuch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Eickholt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rosenmund</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons</article-title>
<source/>eLife
          <year>2016</year>
<volume>5</volume>
<elocation-id>e19374</elocation-id>
<pub-id pub-id-type="pmid">27782879</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bathina</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>UN</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and its clinical implications</article-title>
<source/>Arch Med Sci
          <year>2015</year>
<volume>11</volume>
<fpage>1164</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="pmid">26788077</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YT</given-names>
</name>
</person-group>
<article-title>Excitotoxicity and stroke: identifying novel targets for neuroprotection</article-title>
<source/>Prog Neurobiol
          <year>2014</year>
<volume>115</volume>
<fpage>157</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">24361499</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>English</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Vigers</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Genetic evidence that brain-derived neurotrophic factor mediates competitive interactions between individual cortical neurons</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2012</year>
<volume>109</volume>
<fpage>19456</fpage>
<lpage>19461</lpage>
<pub-id pub-id-type="pmid">23129644</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasuda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukuchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kawahara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsuneki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsuda</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Robust stimulation of TrkB induces delayed increases in BDNF and Arc mRNA expressions in cultured rat cortical neurons via distinct mechanisms</article-title>
<source/>J Neurochem
          <year>2007</year>
<volume>103</volume>
<fpage>626</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="pmid">17711418</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Mazei-Robison</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>LaPlant</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Egervari</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Braunscheidel</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Adank</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Scobie</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Damez-Werno</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Peña</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Labnté</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hodes</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Browne</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chadwick</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Robison</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Vialou</surname>
<given-names>VF</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lorsch</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Mouzon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Neve</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Epigenetic basis of opiate suppression of BDNF gene expression in the ventral tegmental area</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>415</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">25643298</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Khare</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dani</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression</article-title>
<source/>Neuron
          <year>2006</year>
<volume>49</volume>
<fpage>341</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">16446138</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Seoh</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Hyperoxygenation revitalizes Alzheimer's disease pathology through the upregulation of neurotrophic factors</article-title>
<source/>Aging Cell
          <year>2019</year>
<volume>18</volume>
<elocation-id>e12888</elocation-id>
<pub-id pub-id-type="pmid">30746828</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>VB</given-names>
</name>
<name>
<surname>Klistorner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders</article-title>
<source/>Int J Mol Sci
          <year>2013</year>
<volume>14</volume>
<fpage>10122</fpage>
<lpage>10142</lpage>
<pub-id pub-id-type="pmid">23670594</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Laherty</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Eisenman</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</article-title>
<source/>Nature
          <year>1998</year>
<volume>393</volume>
<fpage>386</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="pmid">9620804</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahgoub</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kavalali</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Chahrour</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Monteggia</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>MeCP2 and histone deacetylases 1 and 2 in dorsal striatum collectively suppress repetitive behaviors</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<fpage>1506</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="pmid">27668390</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Self-amplifying autocrine actions of BDNF in axon development</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>18430</fpage>
<lpage>18435</lpage>
<pub-id pub-id-type="pmid">22025720</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Fig. 1</label>
<caption>
<title>D2 heterozygous KO mice exposed to maternal separation stress exhibited autistic-like behaviors. (A, B) Experimental design for maternal separation stress, weaning, and subsequent behavioral tests (A). Diagram illustrating maternal separation of pups from their mothers for 3 hours a day and their return (B). Red arrow, time point for sacrifice. (C~E) Representative heatmaps showing exploratory activity in the three-chamber test of wildtype (WT) and D2<sup>+/−</sup> mice raised normally (CON) or after exposure to early-life stress (ELS) (C). The amount of time spent in the social target chamber (St) and empty chamber (E) for WT mice (D) and D2<sup>+/−</sup> mice (E). n= 10~16 animals (WT·CON, p&lt;0.0001; WT·ELS, p=0.0014; D2<sup>+/−</sup>·CON, p=0.0009; D2<sup>+/−</sup> ·ELS, p=0.0543). (F) The amount of sniffing time with a social target for WT mice and D2<sup>+/−</sup> mice in the three-chamber test. n= 8~16 animals (ELS effect, F<sub>(1, 42)</sub>=9.518, p=0.0036; genotype effect, F<sub>(1, 42)</sub>=10.94, p=0.0019; ELS x genotype interaction, F<sub>(1, 42)</sub>=4.454, p=0.0408). (G) The amount of time spent in social interaction with facial and anogenital sniffing (G) of WT and D2<sup>+/−</sup> mice raised normally or after exposure to early-life stress. n= 8~16 animals (ELS effect, F<sub>(1, 43)</sub>=7.448, p=0.0092; genotype effect, F<sub>(1, 43)</sub>=7.947, p=0.0073; genotype x ELS interaction, F<sub>(1, 43)</sub>=7.301, p=0.0098). (H, I) Locomotion (H) and grooming behaviors (I) in the open field test of WT and D2<sup>+/−</sup>mice raised normally or after exposure to early-life stress. n= 6~16 animals. (Grooming: ELS effect, F<sub>(1, 35)</sub>=2.632, p=0.1137; genotype effect, F<sub>(1, 35)</sub>=3.995, p=0.0534; genotype x ELS interaction, F<sub>(1, 35)</sub> =6.035, p=0.0191). Data are presented as mean±SEM. <sup>*</sup> and <sup>**</sup> denote differences between the indicated groups at p&lt;0.05 and p&lt;0.01, respectively (Student's t-test, two-way ANOVA and Holm-Sidak post hoc test).</title>
</caption>
<graphic xlink:href="en-28-337-g001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Fig. 2</label>
<caption>
<title>D2 heterozygous pups exhibited increased HPA axis response to early-life stress. (A) Experimental design for treatment with early-life stress and time points for obtaining samples. Red arrows, time points for sacrifice. (B) Corticosterone levels of WT and D2<sup>+/−</sup> pups raised normally or after exposure to ELS. ELS-exposed groups and their control pups were sacrificed on postnatal day 14. n=4~5 animals for each group, each with duplicate. (ELS effect, F<sub>(1, 33)</sub>=7.421, p=0.0102; genotype effect, F<sub>(1, 33)</sub>=0.1043, p=0.7488; genotype x ELS interaction, F<sub>(1, 33)</sub>=2.466, p=0.1259). (C) Corticosterone levels of WT and D2<sup>+/−</sup> mice raised normally or after exposure to ELS, and sacrificed on postnatal day 70. To induce a stress response, the mice were exposed to 60-min restraint (rst-60) and then sacrificed. n=4~7 animals for each group, each with duplicate. Data are presented as mean±SEM. <sup>*</sup> and <sup>**</sup> denote differences between the indicated groups at p&lt;0.05 and p&lt;0.01, respectively (One-way, two-way ANOVA and Holm-Sidak post hoc test).</title>
</caption>
<graphic xlink:href="en-28-337-g002"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Fig. 3</label>
<caption>
<title>Early-life stress in D2<sup>+/−</sup> mice induced altered expression of BDNF-TrkB signaling in the dorsal striatum. (A) Experimental design for treatment with early-life stress, weaning, and time points for sacrifice. A diagram showing the regions (circles) in the dorsal striatum used for tissue prep (right panel). (B, C) Real-time PCR data showing transcript levels of <italic>TrkB</italic>, <italic>tBdnf</italic>, <italic>Bdnf1</italic>, and <italic>Bdnf4</italic> (B), and <italic>Mecp2</italic>, <italic>Hdac1</italic>, <italic>Hdac2</italic>, <italic>Hdac3</italic>, <italic>Hdac4</italic>, and <italic>Hdac5</italic> (C) in the dorsal striatum of WT and D2 heterozygous KO pups raised normally or after exposure to early-life stress. Tissue samples were prepared on postnatal day 14. n=4~6 animals, 4~6 PCR repeats (<italic>TrkB</italic>: ELS effect, F<sub>(1, 12)</sub>=18.12, p=0.0011; genotype effect, F<sub>(1, 12)</sub>=0.1136, p=0.7419; ELS x genotype interaction, F<sub>(1, 12)</sub>=9.483, p=0.0095; <italic>tBdnf</italic>: ELS effect, F<sub>(1, 12)</sub>=4.962, p=0.0458; genotype effect, F<sub>(1, 12)</sub>=0.3740, p=0.5523; ELS x genotype interaction, F<sub>(1, 12)</sub>=0.2762, p=0.6088; <italic>Hdac1</italic>: ELS effect, F<sub>(1, 20)</sub>=0.5866, p=0.4527; genotype effect, F<sub>(1, 20)</sub>=23.25, p=0.0001; ELS x genotype effect; F<sub>(1, 20)</sub>=6.090, p=0.0227; <italic>Hdac3</italic>: ELS effect, F<sub>(1, 20)</sub>=0.0.8137, p=0.3778; genotype effect, F<sub>(1, 20)</sub>=11.24, p=0.0032; ELS x genotype effect, F<sub>(1, 20)</sub>=0.1040, p=0.7504). (D, E) Real-time PCR data showing transcript levels of <italic>TrkB</italic>, <italic>tBdnf</italic>, <italic>Bdnf4</italic> (D), <italic>Mecp2</italic>, <italic>Hdac1</italic>, <italic>Hdac2</italic>, <italic>Hdac3</italic>, <italic>Hdac4</italic>, and <italic>Hdac5</italic> (E) in the dorsal striatum of WT and D2 heterozygous KO mice raised normally or after exposure to ELS, and sacrificed on postnatal day 70. n=4–6 animals, 3~6 PCR repeats (<italic>TrkB</italic>: ELS effect, F<sub>(1, 14)</sub> =276.5, p&lt;0.0001; genotype effect, F<sub>(1, 14)</sub>=53.77, p&lt;00001; ELS x genotype interaction, F<sub>(1, 14)</sub>=179.5, p&lt;0.0001; <italic>tBdnf</italic>: ELS effect, F<sub>(1, 12)</sub>=2.902, p=0.1142; genotype effect, F<sub>(1, 12)</sub>=10.83, p=0.0064; ELS x genotype interaction, F<sub>(1, 12)</sub>=4.888, p=0.0472; <italic>Bdn4f</italic>: ELS effect, F<sub>(1, 8)</sub>=2.734, p=0.1369; genotype effect, F<sub>(1, 8)</sub> =26.33, p=0.0009; ELS x genotype interaction, F<sub>(1, 8)</sub>=14.65, p=0.0050; <italic>Mecp2</italic>: ELS effect, F<sub>(1, 15)</sub>=17.80, p=0.0007; genotype effect, F<sub>(1, 15)</sub>=7.572, p=0.0148; ELS x genotype effect, F<sub>(1, 15)</sub>=9.961, p=0.0065; <italic>Hdac2</italic>; ELS effect, F<sub>(1, 16)</sub>=20.81, p=0.0003; genotype effect, F<sub>(1, 16)</sub>=6.247, p=0.0237; ELS x genotype effect, F<sub>(1, 16)</sub>=12.25, p=0.0030; <italic>Hdac3</italic>: ELS effect, F<sub>(1, 12)</sub>=7.365, p=0.0188; genotype effect, F<sub>(1, 12)</sub>=10.02, p=0.0081; ELS x genotype effect, F<sub>(1, 12)</sub>=0.08215, p=0.7739; <italic>Hdac5</italic>: ELS effect, F<sub>(1, 12)</sub>=0.06437, p=0.8040; genotype effect, F<sub>(1, 12)</sub>=1.741, p=0.2117; ELS x genotype effect, F<sub>(1, 12)</sub>=0.7854, p=0.3929). (F~I) Western blots showing TrkB, BDNF, MeCP2 (F), p-AKT, AKT, p-ERK1/2, ERK1/2, p-CREB, CREB and β-Actin (H) levels in the dorsal striatum of WT mice and D2 heterozygous KO mice raised normally or or after exposure to early-life stress, and sacrificed on postnatal day 70. Quantification of Western blots (G, I). n=6~8 animals, 3~5 repeats (TrkB: ELS effect, F<sub>(1, 8)</sub>=0.6597, p=0.4402; genotype effect, F<sub>(1, 8)</sub>=20.88, p=0.0018; genotype x ELS interaction, F<sub>(1, 8)</sub>=7.630, p=0.0246; BDNF: ELS effect, F<sub>(1, 8)</sub>= 3.428, p=0.1012; genotype effect, F<sub>(1, 8)</sub>=1.998, p=0.1953; genotype x ELS interaction, F<sub>(1, 8)</sub>=13.14, p=0.0067; MeCP2: ELS effect, F <sub>(1, 16)</sub>=5.085, p=0.0385; genotype effect, F<sub>(1, 16)</sub>=18.71, p=0.0005; genotype x ELS interaction, F<sub>(1, 16)</sub>=22.01, p=0.0002). Data are presented as mean±SEM. <sup>*</sup> and <sup>**</sup> denote differences between the indicated groups at p&lt;0.05 and p&lt;0.01, respectively (Two-way ANOVA and Holm-Sidak post hoc test).</title>
</caption>
<graphic xlink:href="en-28-337-g003"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Fig. 4</label>
<caption>
<title>7,8-DHF treatment rescued autistic-like behaviors in ELS-exposed D2<sup>+/−</sup> mice. (A) Experimental design for treatment with 7,8-DHF, behavioral tests, and time points for sacrifice. 7,8-DHF was intraperitoneally injected at the dose of 10 mg/kg/day for 3 days, and behavioral tests were carried out on day 4. (B, C) Representative heatmaps showing exploratory activity in the three-chamber test of normally raised WT mice and ELS-exposed D2<sup>+/−</sup> mice treated with 7,8-DHF or vehicle (B). The amounts of time spent in each chamber for the mouse groups are presented in (C). n= 5–7 animals (WT, CON+Veh: p&lt;0.0001; WT, CON+DHF: p= 0.0042; D2<sup>+/−</sup>, ELS+Veh: p=0.5986, D2<sup>+/−</sup>; ELS+DHF: p=0.0002). (D, E) The social interaction time spent sniffing in the home-cage social interaction test (D) and grooming time (E) of normally raised WT mice and ELS-exposed D2<sup>+/−</sup> mice treated with 7,8-DHF or vehicle. n=5~7 animals (Home-cage social interaction: genotype effect, F<sub>(1, 19)</sub>=9.227, p=0.0068; DHF effect, F<sub>(1, 19)</sub>=0.5098, p=0.4839; genotype x DHF interaction, F<sub>(1,19)</sub>=2.703, p=0.1166; Grooming: genotype effect, F<sub>(1, 21)</sub>=10.04, p=0.0046; DHF effect, F<sub>(1, 21)</sub>=25.07, p&lt;0.0001; genotype x DHF interaction, F<sub>(1, 21)</sub>=11.75, p=0.0025). (F) Real-time PCR data showing transcript levels of <italic>TrkB</italic>, <italic>tBdnf</italic>, and <italic>Bdnf4</italic> in the dorsal striatum of normally raised WT mice and ELS-exposed D2<sup>+/−</sup> mice treated with 7,8-DHF or vehicle (F). n=3~4 animals, 3~5 PCR repeats (<italic>TrkB</italic>: genotype effect, F<sub>(1, 14)</sub>=5.693, p=0.0317; DHF effect, F<sub>(1, 14)</sub>=11.95, p=0.0039; genotype x DHF interaction, F<sub>(1, 14)</sub>=11.46, p=0.0044). (G~J) Western blots showing TrkB, BDNF (G), p-AKT, AKT, p-ERK1/2, ERK1/2, p-CREB, CREB and β-Actin (I) levels in the dorsal striatum of normally raised WT mice and ELS-exposed D2<sup>+/−</sup> mice treated with 7,8-DHF or vehicle. Quantification of Western blots (H, J). n=3~4 animals, 3~5 repeats (TrkB: genotype effect, F<sub>(1, 12)</sub>=9.596, p=0.0092; DHF effect, F<sub>(1, 12)</sub>=9.814, p=0.0086; genotype x DHF interaction, F<sub>(1, 12)</sub>=0.2431, p=0.6309; BDNF: genotype effect, F<sub>(1, 8)</sub>=1.936, p=0.2015; DHF effect, F<sub>(1, 8)</sub>=3.507, p=0.0980; genotype x DHF interaction, F<sub>(1, 8)</sub>=0.2157, p=0.6547). Data are presented as mean±SEM. <sup>*</sup> and <sup>**</sup> denote differences between the indicated groups at p&lt;0.05 and p&lt;0.01, respectively (Student's t-test or two-way ANOVA followed by Holm-Sidak post hoc test).</title>
</caption>
<graphic xlink:href="en-28-337-g004"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Fig. 5</label>
<caption>
<title>Inhibition of TrkB in the dorsal striatum blocked the therapeutic effects of 7,8-DHF. (A) Experimental designs. In Exp.#1, CON-siRNA or TrkB-siRNA was injected in the dorsal striatum (AP, +1.0; ML, ±1.5; DV, −3.6 mm) of normally raised WT mice, and the mice were sacrificed on day 3. In Exp.#2, CON-siRNA or TrkB-siRNA was injected in the dorsal striatum of normally raised WT mice or ELS-exposed D2<sup>+/−</sup> mice, followed by 7,8-DHF injection (i.p., 10 mg/kg/day) and subsequent behavioral tests. (B, C) Western blots showing expression levels of TrkB, p-AKT, AKT, p-ERK1/2, ERK1/2, and β-Actin in the dorsal striatum injected with TrkB-siRNA or CON-siRNA (B). Samples were collected 2 days after siRNA injection. Quantification of Western blots (C). n= 4 animals, each, 3–4 repeats (TrkB: p=0.0002; p-AKT/AKT: p=0.0367; p-ERK/ERK: p=0.0014). (D~F) The amount of time spent in each chamber in the three-chamber test (D), social interaction time in the home-cage social interaction test (E), and grooming time (F) of normally raised WT mice and ELS-exposed D2<sup>+/−</sup> mice injected with TrkB-siRNA or CON-siRNA in the dorsal striatum and treated with vehicle or 7,8-DHF as indicated. n=5~6 animals (three-chamber test: WT, CON+siCON+Veh: p=0.0017; WT, CON+siTrkB+Veh; p=0.0015; D2<sup>+/−</sup>, ELS+siCON+Veh: p=0.5463, D2<sup>+/−</sup>, ELS+siCON+DHF: p=0.0025, D2<sup>+/−</sup>, ELS+siTrkB+DHF: p=0.9304; Grooming, WT, CON+siCON+Veh vs. WT, CON+siTrkB+Veh: p=0.9081; D2<sup>+/−</sup>, F<sub>(2, 14)</sub>=0.2332, p=0.7950). Data are presented as mean±SEM. <sup>*</sup> and <sup>**</sup> denote differences between the indicated groups at p&lt;0.05 and p&lt;0.01, respectively (Student's t-test or one-way ANOVA and Holm-Sidak post hoc test).</title>
</caption>
<graphic xlink:href="en-28-337-g005"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>